2017 Innovations in Cancer Treatment and Care Conference
The Cancer Institute NSW presented the Innovations in Cancer Treatment and Care Conference on September 14th, 2017 in Sydney at the Sofitel Hote;.
The Innovations Conference 2017 is a free conference for health professionals – providing an opportunity to see, hear, learn, collaborate and share the latest innovations in quality cancer treatment and care.
You can catch up on all tweets that happened via Twitter on #CancerInnovations
What’s on in 2017?
This year’s Conference will carry a key focus on innovations in smoking cessation for people with cancer.
An outline of the program is now available. See the: Innovations Conference 2017 - Program Outline.
Six concurrent sessions have been confirmed:
- Using Technology to Improve Cancer Care
- Patient Centred Care
- Psychosocial Care and Support
- Innovations in Radiation Oncology
- Innovations to support Smoking Cessation
- TCRC Rapid Fire Session
Stay updated for more program details – coming soon.
2017 Keynote – Dr Graham Warren
This year’s keynote speaker is Dr Graham Warren, Associate Professor of the Hollings Cancer Center, Medical University of South Carolina.
Dr Warren’s extensive background in smoking cessation for people with cancer will make him an ideal lead through our Cancer Innovations 2017 discussions.
A Board Certified Radiation Oncologist and the Vice Chairman for Research in the Department of Radiation Oncology, Dr Warren has a primary clinical emphasis in the treatment of gastrointestinal and thoracic malignancies.
He is recognised for his background in smoking cessation, working with a wide range of organisations to increase access to evidence-based tobacco cessation support for cancer patients.
His primary research interests are in:
- Evaluating the clinical and biologic effects of tobacco on cancer treatment response.
- Identifying critical biologic targets to improve therapeutic outcomes in cancer patients exposed to tobacco.
- Optimising behavioural and clinical methods to optimize data collection that can be used for clinical decision making and research.
Find our more about Dr Graham Warren.
MC – Julie McCrossin
We are excited to welcome Julie McCrossin as this year’s Innovations Conference MC. Julie McCrossin gets people talking and she is renowned for her warmth, humour, intelligence and commitment to social justice.
After 20 years as a broadcaster with ABC Radio National, ABC TV and Network Ten, she is now a freelance journalist and facilitator. (Read more)
2017 Discussion Panel
Four expert panel members from across Australia will be part of the 2017 Cancer Innovations discussion panel, focusing on smoking cessation for people with cancer.
The Hon. Nicola Roxon
Nicola Roxon comes from 15 years in Australian federal politics – notably as Minister for Health and Ageing for four years, and Australia’s first female Attorney-General in 2011.
She is recognised for her role spearheading Australia’s plain packaging push, a regulation now being adopted by countries around the world. (Read more)
Find out more about the Hon. Nicola Roxon.
Dr Bronwyn King

Dr King founded Tobacco Free Portfolios with the goal of eliminating tobacco from investment portfolios around the world.
As a Radiation Oncologist at The Peter MacCallum Cancer Centre, she saw first hand the impact of lung cancer on patients. (Read more)
Find out more about Dr Bronwyn King.
Professor Geoff Delaney
Professor Geoff Delaney is a staff specialist in Radiation Oncology at Liverpool and Campbelltown Hospitals, and the Director of Cancer Services for the South West Sydney Local Health District.
He has published research in international literature – over 170 peer-reviewed papers, reports and book chapters – and has a main tumour site interest in breast cancer. (Read more)
Find out more about Professor Geoff Delaney.
Associate Professor Jarad Martin
Associate Professor Jarad Martin is a Radiation Oncologist from Newcastle, managing people with genitourinary and gastrointestinal cancers.
He is the Director of Research (Department of Radiation Oncology) and Radiation Oncologist at the Calvary Mater Newcastle, as well as Visiting Medical Officer at Genesis Cancer Care, Lake Macquarie Private Hospital. (Read more)
Find out more about Associate Professor Jarad Martin.
Associate Professor Philip Beale
Associate Professor Philip Beale is Director of Cancer Services and Director of Palliative Care at Sydney Local Health District, together with roles at Concord, RPA and Chris O'Brien Lifehouse.
In clinical practice Associate Professor Beale has a special interest in ovarian, breast, colorectal and upper gastrointestinal cancers. (Read more)
Find out more about Associate Professor Philip Beale.
Download the app
If you are attending the Conference in 2017, download the official app. It lets you:
- get live notifications
- plan your event
- vote
- learn more about delegates and speakers.
CrowdCompass AttendeeHub is available now for Apple and Android – download it and select 'Innovations in Cancer Treatment and Care Conference 2017'.
More information: App download instructions.
Conference program
Thursday 14 September 2017
8am – 8.30am |
REGISTRATION OPEN |
8.30am– 11am |
PLENARY SESSION 1 |
8.30 - 9am |
|
9.10am– 9.40am |
Keynote Address |
9.40am – 9.50am |
Audience Feedback |
9.50am – 11am |
Panel Discussion - The responsibility of cancer health professionals to support smoking cessation The Hon. Nicola Roxon, Former Minister for Health and Chair of Cancer Council Australia Dr Graham Warren, Vice Chairman for the Research in Radiation Oncology, Department of Radiation Oncology, Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Hollings Cancer Center, Medical University of South Carolina Dr Bronwyn King, Radiation Oncologist and CEO Tobacco Free Portfolios Prof Geoff Delaney, Director of Cancer Services, South Western Sydney Local Health District Dr Jarad Martin, Director of Research (Department of Radiation Oncology) and Radiation Oncologist, Calvary Mater, Newcastle A/Prof Philip Beale, Director of Cancer Services, Sydney Local Health District |
11am – 11.30am |
MORNING TEA (30 mins) |
11.30am – 1pm |
MORNING CONCURRENT SESSIONS |
A |
Using Technology to Improve Cancer Care |
11:30am - 11:45am |
13 11 20 information and support service – your navigation through Cancer |
11:50am - 12:05pm |
PREXIT – paper records exit into an electronic era |
12:10pm - 12:25pm |
Increasing psychosocial support through digital channels |
12:30pm - 12:45pm |
Increasing cross-referral and recruitment to clinical trials: a new APProach |
12:45pm - 1pm |
The healthy living after cancer partnership project: telephone health coaching and additional SMS support for cancer survivors |
B: |
Patient Centred Care |
11:30am - 11:45am |
Lessons learned in improving access to colonoscopy for the National Bowel Cancer Screening Program |
11:50am - 12:05pm |
The RoaDmaP pilot study: feasibility of implementing a primary care intervention for referral of potential lung cancer cases to specialist care |
12:10pm - 12:25pm |
Yarning about cancer |
12:30pm - 12:45pm |
What patients want: streamlining radiation oncology patient information across the Illawarra and Shoalhaven cancer care centres |
12:45pm - 1pm |
Best evidence to best practice: implementing an innovative model of care for nutrition management of patients with head and neck cancer – outcomes and impact |
C: |
TCRC Rapid Fire Session (6 min presentation) |
11:30am - 11:39am |
A novel approach to the management of radiation oncology clinical trials; focus on quality, processes and improving participation |
11:39am - 11:48am |
The quest towards better data collection, automation, and scalability – a lung MDT case study |
11:48am - 11:57am |
Cancer research participation by culturally and linguistically diverse patients in South Western Sydney from 2006-2016: A retrospective analysis |
11:57am - 12:06pm |
A retrospective pharmaceutical financial benefits analysis of clinical trial participation |
12:06pm - 12:15pm |
Embedding research (and evidence) in cancer healthcare – the EnRICH program |
12:15pm - 12:24pm |
Does timeliness of care in non-small cell lung cancer impact on survival? |
12:24pm - 12:33pm |
Chemotherapy-induced peripheral neuropathy in Australian cancer survivors |
12:33pm - 12:42pm |
Evidence-practice gaps in distress management for cancer patients and preferred implementation strategies: a national cross-sectional survey |
12:42pm - 12:51pm |
Improving regional patients’ in HNE LHD access to the optimal care pathway for ovarian cancer |
12:51pm - 1pm |
Reoperation after breast conserving surgery for cancer 2002-2013, NSW, Australia |
|
Judging |
1pm - 1:45pm |
LUNCH (45 minutes) |
1:45pm - 3pm |
AFTERNOON CONCURRENT SESSIONS |
A: |
Innovations to Support Smoking Cessation |
1:45pm - 2pm |
Development of the NSW smoking cessation framework |
2pm - 2:15pm |
Preliminary findings from an evaluation of the barriers for carers in supporting mental health consumers to quit smoking |
2:15pm - 2:30pm |
Smoking cessation care in outpatient oncology: patient perspectives |
2:30pm - 2:45pm |
Message 2 quit (M2quit) for smoking cessation: a pilot trial of tailored text-messaging program for Australian low-socioeconomic status smokers |
2:45pm - 3pm |
Smoking and age as factors influencing stable weight in rural patients undergoing radiotherapy for head and neck cancer |
B: |
Psychosocial Care and Support |
1:45pm - 2pm |
Indigenous Australians and cancer care – closing the gap |
2pm - 2:15pm |
What do Radiation Therapists know about patient anxiety? |
2:15pm - 2:30pm |
Evaluating patient information: understanding cancer booklets |
2:30pm - 2:45pm |
Chinese women with breast cancer: challenges, coping strategies and supportive care needs |
2:45pm - 3pm |
Recognise; respond; resilience; managing compassion fatigue in oncology nurses |
C: |
Innovations in Radiation Oncology |
1:45pm - 2pm |
Radiotherapy patterns of care for stage I and II non-small cell lung cancer in Sydney, Australia |
2pm - 2:15pm |
Criterion-based benchmarking approach of the appropriate use of radiotherapy in NSW-ACT, Australia |
2:15pm - 2:30pm |
Evidence-based population model of local control and overall survival benefit of radiotherapy |
2:30pm - 2:45pm |
Eating as treatment: improving treatment outcomes for head and neck cancer patients undergoing radiotherapy |
2:45pm - 3pm |
Which bowel preparation works best? A randomised control trial comparing a bulking and osmotic laxative in achieving an empty rectum for prostate radiation therapy |
3pm - 3:30pm |
AFTERNOON TEA (30 mins) |
3:30pm - 5pm |
PLENARY SESSION 2 |
3:30pm - 3:50pm |
The Role of Smoking Cessation in Clinical Oncology. Australian oncologists experiences, preference and practices |
3:50pm - 4pm |
Audience feedback |
4pm - 4:50pm |
|
4pm - 4:06pm |
An evaluation of the effectiveness of a smoking cessation e-learning training for community sector professionals |
4:06pm - 4:11pm |
Judges feedback |
4:11pm - 4:17pm |
How do NSW hospitals promote smoking cessation care for patients with cancer |
4:17pm - 4:22pm |
Judges feedback |
4:22pm - 4:27pm |
Shaping interventions to address waterpipe smoking in an Arabic speaking community in Australia: a qualitative study |
4:27pm - 4:32pm |
Judges feedback |
4:32pm - 4:38pm |
Continued smoking after a cancer diagnosis – a longitudinal study of intentions and attempts to quit |
4:38pm - 4:50pm |
Judges feedback |
4:50pm - 5pm |
Presentations, Judging and Closing |
5pm - 6pm |
NETWORKING FUNCTION (Drinks and Canapés) |
6pm |
CONFERENCE CONCLUDES |
Conference Posters
The following posters will be displayed during the conference:
8. Survivors Teaching Students: Saving Women's Lives (STS) - ANZGOG's ovarian cancer learning initiative for health professional students
10. Improving patient engagement in melanoma clinical trials
14. Medicolegal Considerations in Multidisciplinary Lung Cancer Care
15. Follow-up of Stage I-III Non-Small Cell Lung Cancer: Who, When and How?
17. Cytisine versus varenicline for smoking cessation: A study protocol for a single-blind randomised controlled non-inferiority clinical trial
18. Improved Clinical Documentation for Improved Communication
19. Nurse led Vascular Access Team (VAT) St George Hospital Cancer Services